The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

Stian Knappskog, Merete Bjornslett, Line M. Myklebust, Petra E. A. Huijts, Maaike P. Vreeswijk, Hege Edvardsen, Yongli Guo, Xuemei Zhang, Ming Yang, Sanna K. Ylisaukko-oja, Pia Alhopuro, Johanna Arola, Rob A. E. M. Tollenaar, Christi J. van Asperen, Caroline Seynaeve, Vidar Staalesen, Ranjan Chrisanthar, Erik Lokkevik, Helga B. Salvesen, D. Gareth EvansWilliam G. Newman, Dongxin Lin, Lauri A. Aaltonen, Anne-Lise Borresen-Dale, Grethe S. Tell, Camilla Stoltenberg, Pal Romundstad, Kristian Hveem, Johan R. Lillehaug, Lars Vatten, Peter Devilee, Anne Dorum, Per E. Lonning

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer Cell
Volume19
Issue number2
Pages (from-to)273-282
Number of pages10
ISSN1535-6108
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fields of Science

  • SINGLE NUCLEOTIDE POLYMORPHISM
  • ACCELERATES TUMOR-FORMATION
  • SNP309 POLYMORPHISM
  • ATM GENE
  • ASSOCIATION
  • MUTATIONS
  • SUSCEPTIBILITY
  • PROTEIN
  • AMPLIFICATION
  • ONCOPROTEIN
  • 3122 Cancers
  • 3111 Biomedicine

Cite this